However, mutation analysis indicated that coamplification of the HER2 gene with its proximal 200 kb CDK12 was commonly observed in HER2-positive breast cancer, accounting for approximately 90% of cases8,9. The gene discussed is ERBB2; the disease is breast carcinoma.